| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Isotretinoin | FAERS: 4 | US FAERS | |
| 2 | Capecitabine | FAERS: 2 | OFFSIDES US FAERS | |
| 3 | Meloxicam | FAERS: 2 | US FAERS | |
| 4 | Cisapride | FAERS: 1 | US FAERS | |
| 5 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 6 | Fentanyl | FAERS: 1 | US FAERS | |
| 7 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 8 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 9 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 10 | riociguat | FAERS: 1 | US FAERS | |
| 11 | Lenalidomide | OFFSIDES | ||
| 12 | Tenofovir | OFFSIDES | ||
| 13 | acetaminophen, dextropropoxyphene, drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.